Aileron Therapeutics is a biotechnology business based in the US. Aileron Therapeutics shares (ALRN) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.11 – the same closing value as a week prior. Aileron Therapeutics employs 15 staff and has a market cap (total outstanding shares value) of 0.00.
Offer ends 4/1/25. Customer must fund their Active invest account with at least $50 within 30 days of opening the account. Probability of customer receiving $2,000 is 0.028%. See full terms and conditions at https://www.sofi.com/greenintwoterms/.
Open an account.Provide your personal information and sign up.
Fund your account.Deposit funds into your account by linking your banking information or transfer funds from another trading account.
Search for the stock name – ALRN.Search for the stock by name or ticker symbol.
Buy the stock. Place your order. It's that simple.
Buy Aileron Therapeutics stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Aileron Therapeutics stock price (NASDAQ: ALRN)
Use our graph to track the performance of ALRN stocks over time.
Is it a good time to buy Aileron Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Aileron Therapeutics price performance over time
Historical closes compared with the close of $2.11 from 2025-01-10
1 week (2025-03-14)
N/A
1 month (2025-02-21)
N/A
3 months (2024-12-24)
-2.76%
6 months (2024-09-25)
-34.27%
1 year (2024-03-25)
-64.12%
2 years (2023-03-24)
51.83%
3 years (2022-03-25)
11.552
5 years (2020-03-25)
7.622
Aileron Therapeutics financials
Gross profit TTM
$-17,008,000
Return on assets TTM
-25.86%
Return on equity TTM
-44.32%
Profit margin
0%
Book value
$1.41
Market Capitalization
$45.7 million
TTM: trailing 12 months
Aileron Therapeutics share dividends
We're not expecting Aileron Therapeutics to pay a dividend over the next 12 months.
Have Aileron Therapeutics's shares ever split?
Aileron Therapeutics's shares were
split on a 1:20 basis on 13 November 2022
. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aileron Therapeutics shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Aileron Therapeutics shares which in turn could have impacted Aileron Therapeutics's share price.
Aileron Therapeutics share price volatility
Over the last 12 months, Aileron Therapeutics's shares have ranged in value from as little as $1.61 up to $7.42. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aileron Therapeutics's is 2.341. This would suggest that Aileron Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Aileron Therapeutics overview
Aileron Therapeutics, Inc. , a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate is LTI-03, a peptide, which is in Phase 1b clinical trial for the treatment of idiopathic pulmonary fibrosis (IPF). Its second product candidate is LTI-01, a proenzyme that has completed Phase 1b and Phase 2a clinical trials in LPE patients for the treatment of loculated pleural effusion. The company's pipeline also includes preclinical programs targeting cystic fibrosis and a peptide program focused on the caveolin-1 protein for systemic fibrosis indications. The company was formerly known as Renegade Therapeutics, Inc. and changed its name to Aileron Therapeutics, Inc.
Frequently asked questions
null What percentage of Aileron Therapeutics is owned by insiders or institutions? Currently 0.65% of Aileron Therapeutics shares are held by insiders and 28.473% by institutions.How many people work for Aileron Therapeutics? Latest data suggests 15 work at Aileron Therapeutics.When does the fiscal year end for Aileron Therapeutics? Aileron Therapeutics's fiscal year ends in December.Where is Aileron Therapeutics based? Aileron Therapeutics's address is: 12407 N. Mopac Expy., Austin, TX, United States, 78758What is Aileron Therapeutics's ISIN number? Aileron Therapeutics's international securities identification number is: US00887A1051What is Aileron Therapeutics's CUSIP number? Aileron Therapeutics's Committee on Uniform Securities Identification Procedures number is: 00887A105
A deep dive into the highlights and limitations of Robinhood.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.
